4. Treatment of DS-TB using the 4-month 2HPMZ 2HPM regimen Patients aged 12 years or older with pulmonary DS-TB may receive a 4-month regimen of isoniazid, rifapentine, moxifloxacin and pyrazinamide (2HPMZ 2HPM) (Conditional recommendation, moderate certainty of evidence) – new recommendation
Comparing the Costs of Various Treatments for Benign Prostatic Hyperplasia At Cleveland Clinic, surgical costs, based on 2017 Medicare reimbursement, ranged from $1,677 for outpatient transurethral resection of the prostate (TURP) to $2,127 for laser prostatectomy, with higher costs for procedures warranting inpatient status
4-month DS-TB regimen: Evidence gaps and next steps - TB Think Tank regimen for adults (2HPMZ 2HPM) • Although subgroup analysis suggested regimen less efficacious in those with extensive disease, WHO guidelines suggest 4-month regimen can be used in patients with extensive disease
2. Treatment of drug-susceptible TB using 4-month regimens In all, 90% of the cost of medicines for the 2HPMZ 2HPM regimen comes from the rifapentine component Equity : Shorter-term and longer-term equity considerations were raised by GDG members
Definitions - tbksp. who. int 2HPMZ 2HPM) regimen Module 4: Treatment and Care, Chapter 1: Drug-susceptible tuberculosis treatment 4-month regimen: 2 H-P-M-Z 2 H-P-M Initial phase: 2 H-P-M-Z Continuation phase: 2 H-P-M Continuation phase involves 2 months of daily isoniazid, rifapentine and moxifloxacin
2022 . Volume 46 20 . Volume46hot4ut4t6pVs4eeo:4Vl4 Patients aged 12 years or older with pul-monary DS-TB may receive a four-month regimen of isoniazid, rifapentine, moxifloxa-cin and pyrazinamide (2HPMZ 2HPM) (Conditional recommendation, moderate certainty of evidence); and
A 4-Month Regimen to Treat Pulmonary Tuberculosis: Isoniazid . . . A 4-Month Regimen to Treat Pulmonary Tuberculosis: Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide (HPMZ) What is the 4-month HPMZ Regimen for treatment of drug susceptible TB? The HPMZ regimen consists of an 8-week intensive phase of isoniazid (H), rifapentine (P), moxifloxacin (M), and pyrazinamide
Singapore tuberculosis (TB) clinical management guidelines 2024: A . . . An alternative regimen, should rifapentine become available in Singapore, is an 8-week intensive phase of daily H, rifapentine (P), moxifloxacin (M) and Z, followed by 9-week continuation phase of daily H, P and M (2HPMZ 2HPM)—except in pregnant breastfeeding women and PLHIV (Adopted)